In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
February 7th, 2009 | 28 | Yes |
Popular Name: (3S)-5-methyl-3-[[(3R)-1-[3-(4-piperidyl)propanoyl]piperidine-3-carbonyl]amino]hexanoic (3S)-5-methyl-3-[[(3R)-1-[3-(4-p…
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.63 | 7.68 | -98.53 | 3 | 7 | 0 | 106 | 395.544 | 9 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ITA2B-1-E | Integrin Alpha-IIb (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2 | 0.43 | Binding ≤ 10μM |
ITB3-1-E | Integrin Beta-3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2 | 0.43 | Binding ≤ 10μM |
PAR1-2-E | Proteinase Activated Receptor 1 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 4000 | 0.27 | Functional ≤ 10μM |
Z50587-4-O | Homo Sapiens (cluster #4 Of 9), Other | Other | 4000 | 0.27 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ITA2B_HUMAN | P08514 | Integrin Alpha-IIb, Human | 2 | 0.43 | Binding ≤ 1μM |
ITB3_HUMAN | P05106 | Integrin Beta-3, Human | 2 | 0.43 | Binding ≤ 1μM |
ITA2B_HUMAN | P08514 | Integrin Alpha-IIb, Human | 2 | 0.43 | Binding ≤ 10μM |
ITB3_HUMAN | P05106 | Integrin Beta-3, Human | 2 | 0.43 | Binding ≤ 10μM |
Z50587 | Z50587 | Homo Sapiens | 4000 | 0.27 | Functional ≤ 10μM |
PAR1_HUMAN | P25116 | Proteinase Activated Receptor 1, Human | 4000 | 0.27 | Functional ≤ 10μM |
Description | Species |
---|---|
ECM proteoglycans | |
Elastic fibre formation | |
G alpha (q) signalling events | |
GRB2:SOS provides linkage to MAPK signaling for Integrins | |
Integrin alphaIIb beta3 signaling | |
Integrin cell surface interactions | |
Molecules associated with elastic fibres | |
p130Cas linkage to MAPK signaling for integrins | |
PECAM1 interactions | |
Peptide ligand-binding receptors | |
Platelet degranulation | |
Signal transduction by L1 | |
Syndecan interactions | |
Thrombin signalling through proteinase activated receptors (PARs) | |
VEGFA-VEGFR2 Pathway |